《滬深兩市》上證深成高開0.2%-0.4% 醫藥相關股續跌 寧德時代高開
內地昨日(22日)新增本土確診病例2,591例,新增本土無症狀感染者2,346例。人民銀行今日(23日)進行200億元人民幣(下同)7天期逆回購操作,單日淨投放100億元。人民幣兌美元中間價今上調106點。上證深成今早高開。
上證綜指高開4點或0.2%,開報3,264點;深證成指高開54點或0.4%,開報12,373點;創業板指高開19點或0.7%,報2,707點。
中資金融股無明顯方向,工行(601398.SH)低開0.2%。建行(601939.SH)平開。
醫藥概念股持續回吐,華海藥業(600521.SH)、普洛藥業(000739.SZ)、九洲藥業(603456.SH)低開0.8%-2.8%。
盛新鋰能(002240.SZ)引入比亞迪(002594.SZ)作爲戰略投資者,股價開市分別升2.6%及2.1%。寧德時代(300750.SZ)高開1.4%。(ta/k) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.